Skip to main content
. 2012 May 22;61(7):967–978. doi: 10.1007/s00262-012-1282-9

Fig. 5.

Fig. 5

Harmonization of the gating strategy results in acceptable low variation between laboratories participating in phase 3. The coefficient of variation (CV) value is given for the initial analysis of the in silico gating ICS panel (white bars) and after instruction of three participants, who then performed a re-analysis (black bars) only for the positive reactive donor (D)-antigen (CMV or FLU) combination. The CV values dropped after harmonization of the gating strategy